Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995;287(6):558-63.
doi: 10.1007/BF00374076.

FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice

F Furukawa  1 , S Imamura, M Takigawa
Affiliations

FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice

F Furukawa et al. Arch Dermatol Res. 1995.

Abstract

The effects of FK506, a new immunosuppressive agent, on the development of lupus dermatoses were investigated in the autoimmune-prone MRL/Mp-lpr/lpr (MRL/lpr) mouse, which is an animal model for the spontaneous development of skin lesions similar to those of human lupus erythematosus (LE). FK506 reduced the incidence of skin lesions, lupus nephritis, the titre of serum anti-double-stranded DNA antibodies and the massive T cell proliferation. The incidence and magnitude of IgG deposition at the dermoepidermal junction were not changed. These results suggest that FK506 is a promising immunosuppressive agent for the control of autoimmune skin diseases.

PubMed Disclaimer

References

    1. J Antibiot (Tokyo). 1987 Sep;40(9):1249-55 - PubMed
    1. Autoimmunity. 1992;12(4):303-13 - PubMed
    1. Scand J Immunol. 1986 Oct;24(4):405-11 - PubMed
    1. J Immunol. 1987 Jan 1;138(1):157-63 - PubMed
    1. Transplant Proc. 1989 Feb;21(1 Pt 1):1053-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources